Note: Most Internet Explorer 8 users encounter issues playing the presentation videos. Please update your browser or use a different one if available.

Treatments: Medical and Behavioral Trials and Mechanisms

This session presents novel behavioral and medication trials with emphasis on mechanisms.
Saturday, 4 May 2013: 14:00-16:00
Chamber Hall (Kursaal Centre)
14:00
167.001
Effects of a Targeted Face-Processing Intervention On Visual Attention to Naturalistic Social Scenes
P. Lewis J. M. Moriuchi C. Klaiman J. Wolf L. Herlihy W. Jones A. Klin J. W. Tanaka R. T. Schultz
14:15
167.002
A Psychosexual Training Program for Adolescents with Autism Spectrum Disorder (ASD); The First Effects of the Tackling Teenage Training
K. Visser L. P. Dekker E. van der Vegt F. Boudesteijn F. C. Verhulst A. Maras K. Greaves-Lord
14:30
167.003
Minimally Verbal Children with ASD: Neural Mechanisms and a Novel Speech Intervention
C. Y. Wan B. Scherrer J. Chiew J. L. Colet G. Schlaug
14:45
167.005
Methylphenidate Effects On Hyperactivity in ASD Are Moderated by Monoaminergic Gene Variants
J. T. McCracken M. G. Aman L. Scahill L. E. Arnold C. McDougle B. Vitiello E. L. Nurmi
15:00
167.006
Psychotropic Drug Use and CAM in ASD: Prevalence and Correlates in the Ohsu ATN Site
K. Senn J. B. Roullet L. Voltolina D. A. Fair A. D. Hagen J. Nigg L. Huang-Storms E. Fombonne
15:15
167.007
An Internet-Based Randomized Controlled Trial of Omega-3 Fatty Acids for Hyperactivity in Children with ASD
S. Bent R. L. Hendren T. Zandi J. K. Law F. Widjaja J. E. Choi J. Nestle P. A. Law
15:30
167.008
Extended Oxytocin Treatment of Children with Autistic Disorder
L. Sikich T. C. Bethea C. O. Alderman L. Hazzard C. A. Pedersen N. E. Connelly S. G. Gregory J. L. Johnson
See more of: Treatment Trials: Behavioral Interventions
See more of: Prevalence, Risk factors & Intervention
<< Previous Panel | Next Panel >>